CD86 and COVID-19: The observation of high B7-2 and low CD25 levels-although CD25 differences became non-significant after adjustment for BMI, comorbidities and site-in both CAP-flu and COVID-19 when compared with CAP-other and CAP-strep might indicate a common viral effect on T cell activation.